Drug development is a complicated process, with a huge number of processes and activities required to bring a drug successfully to market. How can an integrated CDMO help a small biotech move a project into and through the clinic, and onto the market? In this podcast, Henny Zijlstra, Senior Director, Commercial Development at Lonza, details why is it faster and more efficient to work with a single supplier.

Author: Henny Zijlstra, Senior Director, Commercial Development, Small Molecules

Content Type: Podcast
Latest content

Latest briefing from the Knowledge Center